| NASDAQ-100 | 2579.78 | -0.40% |
| AEX | 326.77 | -1.13% |

Delphi Bioscience provides solutions for a wide variety of settings in the field of cervical cancer screening. Our approach is based on a patent-protected sampling method with unique woman-friendly characteristics and high yield, resulting in stable and reliable specimens.
Our sampling device offers women, professionals and health authorities the opportunity to increase women’s access to user-friendly and effective screening. Delphi Bioscience has a strong commitment to making cervical cancer screening available to all women.
The Delphi Bioscience Screener (Delphi Bioscience’s self-sampling method) is a lavage-based sampling method, using buffered saline, a safe, body-friendly liquid, which can be used by doctors as well as by women themselves at home. The medical device is a Dutch innovation designed by leading gynaecologists. The sampling technique differs fundamentally from other approaches like brushes and swabs. The Delphi Bioscience Screener is one of the most widely demonstrated self-sampling methods for cervical cancer screening. One of the largest clinical trials for offering women a home self-sampling kit has recently finished and used the Delphi Bioscience Screener.
Scientists across the world are invited to contact us to design and develop projects for their local (screening) settings. We also appreciate contact with organizations and companies who want to explore the improvement of cervical cancer screening coverage and the improved detection of high grade lesions and cancers in different populations.

Neem voor meer informatie over deze participatie contact op met: